BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 1481753)

  • 1. Iodine-125 interstitial irradiation for cerebral gliomas.
    Ostertag CB; Kreth FW
    Acta Neurochir (Wien); 1992; 119(1-4):53-61. PubMed ID: 1481753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interstitial radiosurgery of low grade glioma].
    Kreth FW; Warnke PC; Ostertag CB
    Nervenarzt; 1993 Oct; 64(10):633-9. PubMed ID: 8232676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial radiosurgery of low-grade gliomas.
    Kreth FW; Faist M; Warnke PC; Rossner R; Volk B; Ostertag CB
    J Neurosurg; 1995 Mar; 82(3):418-29. PubMed ID: 7861220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade gliomas -- current concepts.
    Schramm J; Blümcke I; Ostertag CB; Schlegel U; Simon M; Lutterbach J
    Zentralbl Neurochir; 2006 May; 67(2):55-66. PubMed ID: 16673237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
    Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds.
    Voges J; Treuer H; Schlegel W; Pastyr O; Sturm V
    Acta Neurochir Suppl (Wien); 1993; 58():108-11. PubMed ID: 8109270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases.
    Scerrati M; Montemaggi P; Iacoangeli M; Roselli R; Rossi GF
    Acta Neurochir (Wien); 1994; 131(1-2):97-105. PubMed ID: 7709791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
    Watson J; Romagna A; Ballhausen H; Niyazi M; Lietke S; Siller S; Belka C; Thon N; Nachbichler SB
    Radiat Oncol; 2020 Dec; 15(1):275. PubMed ID: 33298103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
    Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
    Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
    Devaux BC; O'Fallon JR; Kelly PJ
    J Neurosurg; 1993 May; 78(5):767-75. PubMed ID: 8468607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial irradiation for newly diagnosed or recurrent malignant gliomas: preliminary results.
    Scerrati M; Roselli R; Montemaggi P; Iacoangeli M; Prezioso A; Rossi GF
    Acta Neurochir Suppl (Wien); 1993; 58():119-22. PubMed ID: 8109273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.
    Videtic GM; Gaspar LE; Zamorano L; Fontanesi J; Levin KJ; Kupsky WJ; Tekyi-Mensah S
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):687-92. PubMed ID: 10524423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
    Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
    J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of late radiation necrosis with transient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas.
    Wowra B; Schmitt HP; Sturm V
    Acta Neurochir (Wien); 1989; 99(3-4):104-8. PubMed ID: 2549766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pineal region tumours treated with interstitial brachytherapy with low activity sources (192-iridium).
    Matsumoto K; Higashi H; Tomita S; Ohmoto T
    Acta Neurochir (Wien); 1995; 136(1-2):21-8. PubMed ID: 8748823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image fusion-guided stereotactic iodine-125 interstitial irradiation of inoperable and recurrent gliomas.
    Julow J; Viola Á; Bálint K; Szeifert GT
    Prog Neurol Surg; 2007; 20():303-311. PubMed ID: 17317999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial radiotherapy of 25 parasellar/clival meningiomas and 19 meningiomas in the elderly. Analysis of short-term tolerance and responses.
    Vuorinen V; Heikkonen J; Brander A; Setälä K; Sane T; Randell T; Paetau A; Pohjola J; Mäntylä M; Jääskeläinen J
    Acta Neurochir (Wien); 1996; 138(5):495-508. PubMed ID: 8800323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic-endoscopic procedures on processes of the cranial midline.
    Hellwig D; Bauer BL; List-Hellwig E; Mennel HD
    Acta Neurochir Suppl (Wien); 1991; 53():23-32. PubMed ID: 1803880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic interstitial irradiation of diencephalic tumors with iridium 192 and iodine 125: 10 years follow-up and comparison with other treatments.
    Etou A; Mundinger F; Mohadjer M; Birg W
    Childs Nerv Syst; 1989 Jun; 5(3):140-3. PubMed ID: 2547523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic interstitial radiotherapy for brain tumors.
    Ostertag CB
    J Neurosurg Sci; 1989; 33(1):83-9. PubMed ID: 2674362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.